These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 30242172)

  • 1. The potential HLA Class I-restricted epitopes derived from LeIF and TSA of Leishmania donovani evoke anti-leishmania CD8+ T lymphocyte response.
    Dikhit MR; Das S; Mahantesh V; Kumar A; Singh AK; Dehury B; Rout AK; Ali V; Sahoo GC; Topno RK; Pandey K; Das VNR; Bimal S; Das P
    Sci Rep; 2018 Sep; 8(1):14175. PubMed ID: 30242172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction and analysis of promiscuous T cell-epitopes derived from the vaccine candidate antigens of Leishmania donovani binding to MHC class-II alleles using in silico approach.
    Kashyap M; Jaiswal V; Farooq U
    Infect Genet Evol; 2017 Sep; 53():107-115. PubMed ID: 28549876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunomodulation mediated through Leishmania donovani protein disulfide isomerase by eliciting CD8+ T-cell in cured visceral leishmaniasis subjects and identification of its possible HLA class-1 restricted T-cell epitopes.
    Amit A; Dikhit MR; Mahantesh V; Chaudhary R; Singh AK; Singh A; Singh SK; Das VN; Pandey K; Ali V; Narayan S; Sahoo GC; Das P; Bimal S
    J Biomol Struct Dyn; 2017 Jan; 35(1):128-140. PubMed ID: 26727289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the immunomodulatory responses of LdODC-derived MHC Class-II restricted peptides against VL.
    Pandey R; Dikhit MR; Kumar A; Dehury B; Pandey K; Topno RK; Das P; Bimal S
    Parasite Immunol; 2020 Apr; 42(4):e12699. PubMed ID: 31976563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immuno-informatics based approaches to identify CD8+ T cell epitopes within the Leishmania donovani 3-ectonucleotidase in cured visceral leishmaniasis subjects.
    Vijayamahantesh ; Amit A; Dikhit MR; Singh AK; Venkateshwaran T; Das VNR; Das P; Bimal S
    Microbes Infect; 2017 Jun; 19(6):358-369. PubMed ID: 28373107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of multi-epitope peptides containing HLA class-I and class-II-restricted epitopes derived from immunogenic Leishmania proteins, and evaluation of CD4+ and CD8+ T cell responses induced in cured cutaneous leishmaniasis subjects.
    Hamrouni S; Bras-Gonçalves R; Kidar A; Aoun K; Chamakh-Ayari R; Petitdidier E; Messaoudi Y; Pagniez J; Lemesre JL; Meddeb-Garnaoui A
    PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008093. PubMed ID: 32176691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioinformatics analyses of immunogenic T-cell epitopes of LeIF and PpSP15 proteins from Leishmania major and sand fly saliva used as model antigens for the design of a multi-epitope vaccine to control leishmaniasis.
    Bordbar A; Bagheri KP; Ebrahimi S; Parvizi P
    Infect Genet Evol; 2020 Jun; 80():104189. PubMed ID: 31931259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine potential of HLA-A2 epitopes from Leishmania Cysteine Protease Type III (CPC).
    Dikhit MR; Amit A; Singh AK; Kumar A; Mansuri R; Sinha S; Topno RK; Mishra R; Das VNR; Pandey K; Sahoo GC; Ali V; Bimal S; Das P
    Parasite Immunol; 2017 Sep; 39(9):. PubMed ID: 28665520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mining the Proteome of Leishmania donovani for the Development of Novel MHC Class I Restricted Epitope for the Control of Visceral Leishmaniasis.
    Dikhit MR; ; Kumar A; Amit A; Dehury B; Nathsharma YP; Ansari MY; Ali V; Topno RK; Das V; Pandey K; Sahoo GC; Bimal S; Das P
    J Cell Biochem; 2018 Jan; 119(1):378-391. PubMed ID: 28585770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico analysis of six known Leishmania major antigens and in vitro evaluation of specific epitopes eliciting HLA-A2 restricted CD8 T cell response.
    Seyed N; Zahedifard F; Safaiyan S; Gholami E; Doustdari F; Azadmanesh K; Mirzaei M; Saeedi Eslami N; Khadem Sadegh A; Eslami Far A; Sharifi I; Rafati S
    PLoS Negl Trop Dis; 2011 Sep; 5(9):e1295. PubMed ID: 21909442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA class I-restricted T cell epitopes of the kinetoplastid membrane protein-11 presented by Leishmania donovani-infected human macrophages.
    Basu R; Roy S; Walden P
    J Infect Dis; 2007 May; 195(9):1373-80. PubMed ID: 17397010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An immunoprophylactic evaluation of
    Pandey RK; Dikhit MR; Lokhande KB; Pandey K; Das P; Bimal S
    J Biomol Struct Dyn; 2022 Aug; 40(13):6086-6096. PubMed ID: 33602055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An immunoinformatic approach driven by experimental proteomics: in silico design of a subunit candidate vaccine targeting secretory proteins of Leishmania donovani amastigotes.
    Khan MAA; Ami JQ; Faisal K; Chowdhury R; Ghosh P; Hossain F; Abd El Wahed A; Mondal D
    Parasit Vectors; 2020 Apr; 13(1):196. PubMed ID: 32295617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epitope distribution in ordered and disordered protein regions - part A. T-cell epitope frequency, affinity and hydropathy.
    Mitić NS; Pavlović MD; Jandrlić DR
    J Immunol Methods; 2014 Apr; 406():83-103. PubMed ID: 24614036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity evaluation of a rationally designed polytope construct encoding HLA-A*0201 restricted epitopes derived from Leishmania major related proteins in HLA-A2/DR1 transgenic mice: steps toward polytope vaccine.
    Seyed N; Taheri T; Vauchy C; Dosset M; Godet Y; Eslamifar A; Sharifi I; Adotevi O; Borg C; Rohrlich PS; Rafati S
    PLoS One; 2014; 9(10):e108848. PubMed ID: 25310094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Designing of precise vaccine construct against visceral leishmaniasis through predicted epitope ensemble: A contemporary approach.
    Singh G; Pritam M; Banerjee M; Singh AK; Singh SP
    Comput Biol Chem; 2020 Jun; 86():107259. PubMed ID: 32339913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Asymptomatic Epitopes Identified from the Herpes Simplex Virus Tegument Protein VP13/14 (UL47) Preferentially Recall Polyfunctional Effector Memory CD44high CD62Llow CD8+ TEM Cells and Protect Humanized HLA-A*02:01 Transgenic Mice against Ocular Herpesvirus Infection.
    Srivastava R; Khan AA; Garg S; Syed SA; Furness JN; Vahed H; Pham T; Yu HT; Nesburn AB; BenMohamed L
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27847359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elucidation of conserved multi-epitope vaccine against
    Dikhit MR; Sen A
    J Biomol Struct Dyn; 2024; 42(3):1293-1306. PubMed ID: 37054523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low HLA binding of diabetes-associated CD8+ T-cell epitopes is increased by post translational modifications.
    Sidney J; Vela JL; Friedrich D; Kolla R; von Herrath M; Wesley JD; Sette A
    BMC Immunol; 2018 Mar; 19(1):12. PubMed ID: 29562882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficiency and mechanism of antigen-specific CD8+ T-cell activation using synthetic long peptides.
    Zandvliet ML; Kester MG; van Liempt E; de Ru AH; van Veelen PA; Griffioen M; Guchelaar HJ; Falkenburg JH; Meij P
    J Immunother; 2012; 35(2):142-53. PubMed ID: 22306902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.